NCT01893268 2018-05-14
An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical Practice
Hoffmann-La Roche
Completed
Clinical Trials
12 trialsNCT01723878 2017-09-11
ASPET Study: An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced Non-Small Cell Lung Cancer Harbouring EGFR Activating Mutations
Hoffmann-La Roche
Completed
NCT01827852 2017-07-28
AVAdeno Study: An Observational Study of First-Line Avastin (Bevacizumab) in Patients With Adenocarcinoma of the Lung
Hoffmann-La Roche
Completed
NCT01836133 2017-05-04
ELEMENT
Hoffmann-La Roche
Completed
NCT01194050 2016-11-02
An Observational Study of Tarceva (Erlotinib) in Routine Practice For First Line Maintenance Therapy in Patients With Non Small Cell Lung Cancer
Hoffmann-La Roche
Completed
NCT01343914 2016-11-02
An Observational Study on Patients With Non-Squamous NSCLC Who Reached A Long PFS After Avastin (Bevacizumab)-Based First-Line Therapy
Hoffmann-La Roche
Completed
NCT01488331 2016-11-02
An Observational Study of Tarceva (Erlotinib) in Patients With Non-Small Cell Lung Cancer
Hoffmann-La Roche
Completed
NCT01512420 2016-11-02
An Observational Study of Tarceva (Erlotinib) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer With Wild-Type Epidermal Growth Factor Receptor (EGFR) Gene (WILT)
Hoffmann-La Roche
Completed
NCT01790217 2016-11-02
An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer (GERTAC)
Hoffmann-La Roche
Completed
NCT02596958 2016-04-04
Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants
Hoffmann-La Roche
Completed
NCT01664533 2015-12-28
TIME
Hoffmann-La Roche
Completed
NCT01535729 2015-10-29
An Observational Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer
Hoffmann-La Roche
Completed